Absci (ABSI) Non-Current Debt (2020 - 2025)
Absci (ABSI) reported Non-Current Debt of $65000.0 for Q3 2025, down 96.98% on a YoY basis from $2.2 million in Q3 2024, and down 59.63% sequentially from $161000.0 in Q2 2025.
Absci (ABSI) Non-Current Debt (2020 - 2025) Analysis & Trends
Absci (ABSI) has 6 years of Non-Current Debt data on file, last reported at $65000.0 in Q3 2025.
- For the quarter ending Q3 2025, Non-Current Debt fell 96.98% year-over-year to $65000.0; the trailing twelve-month figure through Sep 2025 stood at $65000.0 (down 96.98% YoY), and the FY2024 full-year result was $1.3 million, down 73.03% from the prior year.
- Non-Current Debt eased to $65000.0 in Q3 2025, from $161000.0 in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $8.0 million in Q4 2022 to a low of $65000.0 in Q3 2025.
- A 5-year average of $3.5 million and a median of $3.2 million in 2021 frame the typical range for Non-Current Debt.
- Across the five-year window, Non-Current Debt jumped 1254.05% in 2023 and slumped 96.98% in 2025, its largest moves.
- Tracing ABSI's Non-Current Debt over 5 years: stood at $1.1 million in 2021, then surged by 610.32% to $8.0 million in 2022, then plunged by 41.63% to $4.7 million in 2023, then plunged by 73.03% to $1.3 million in 2024, then plunged by 94.83% to $65000.0 in 2025.
- Business Quant data shows ABSI's Non-Current Debt at $65000.0 in Q3 2025, $161000.0 in Q2 2025, and $682000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 105.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 842.92 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Absci | 1.23 Bn | 1.11 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 65,000.00 |
| Jun 30, 2025 | 161,000.00 |
| Mar 31, 2025 | 682,000.00 |
| Dec 31, 2024 | 1.26 Mn |
| Sep 30, 2024 | 2.16 Mn |
| Jun 30, 2024 | 3.12 Mn |
| Mar 31, 2024 | 3.75 Mn |
| Dec 31, 2023 | 4.66 Mn |
| Sep 30, 2023 | 5.55 Mn |
| Jun 30, 2023 | 6.38 Mn |
| Mar 31, 2023 | 7.19 Mn |
| Dec 31, 2022 | 7.98 Mn |
| Sep 30, 2022 | 6.52 Mn |
| Jun 30, 2022 | 7.13 Mn |
| Mar 31, 2022 | 531,000.00 |
| Dec 31, 2021 | 1.12 Mn |
| Sep 30, 2021 | 1.71 Mn |
| Jun 30, 2021 | 3.35 Mn |
| Dec 31, 2020 | 4.14 Mn |